Preclinical measurement of the amount of state-dependent learning produced by psychoactive drugs
Overton, D.A.
Psychopharmacology Bulletin 15(2): 51-52
1979
ISSN/ISBN: 0048-5764 PMID: 432374 Document Number: 148974
Document emailed within 1 workday
Related Documents
Reddy, D.S. 1998: Preclinical and clinical behavioral paradigms for testing drugs that affect learning and memory processes Methods and Findings in Experimental and Clinical Pharmacology 20(3): 249-277Appleton, W.S. 1971: Psychoactive drugs: a usage guide Diseases of the Nervous System 32(9): 607-616
Sherman, D.S. 1988: Use of psychoactive drugs for the behaviorally disturbed Provider 14(11): 32
Sloan, R.W. 1982: How to minimize side effects of psychoactive drugs Geriatrics 37(5): 51
Nawaz, H.; Khan, A.Alam.; Bukhari, S. 2017: Use Of Psychoactive Drugs Among Medical Undergraduates In Abbottabad Journal of Ayub Medical College Abbottabad: Jamc 29(4): 599-603
Kvale, J.N. 1984: Psychoactive drugs and the frail elderly patient American Family Physician 30(4): 133-140
Roubicek, J.; Matejcek, M.; Porsolt, R. 1975: Computer analysed EEG and behavioral changes after psychoactive drugs International Journal of Neurology 10(1-4): 33-40
Schmidt, R.A. 1971: Retroactive interference and amount of original learning in verbal and motor tasks Research Quarterly 42(3): 314-326
Achong, M.R.; Bayne, J.R.; Gerson, L.W.; Golshani, S. 1978: Prescribing of psychoactive drugs for chronically ill elderly patients Canadian Medical Association Journal 118(12): 1503-1508
Helmchen, H.; Mueller Oerlinghausen, B. 1975: Developing guidelines for the clinical testing of psychoactive drugs Pharmakopsychiatrie Neuro-Psychopharmakologie 8(4): 179-182
Mickis, A.; Rimsiene, G.; Volbekas, V. 1977: The action of some psychoactive drugs on high frequency electrocorticogram Activitas Nervosa Superior 19(Suppl 2): 328-329
Fernández-Crehuet Navajas, J.; Morell Ocaña, J.L.; Guillén Solvas, J.F.; Piédrola De Angulo, G. 1979: Consumption of psychoactive drugs in the university population of Granada Revista de Sanidad E Higiene Publica 53(3-4): 503-522
Randrup, A.; Mogilnicka, E. 1976: Spectrum of pharmacological actions on brain dopamine. Indications for development of new psychoactive drugs. Discussion of amantadines as examples of new drugs with special actions on dopamine systems Polish Journal of Pharmacology and Pharmacy 28(6): 551-556
Nuñez-López, J.A. 1983: Use of psychoactive drugs by the primary care physician. General principles Boletin de la Asociacion Medica de Puerto Rico 75(6): 284-287
Krauss, P.F. 1976: Social dimensions in the use of prescription psychoactive drugs (diet pills) Addictive Diseases 2(4): 659-672
Chavez, M.L.; Chavez, P.I. 1990: Use of psychoactive drugs for nontherapeutic reasons by pharmacy students in Puerto Rico American Journal of Hospital Pharmacy 47(11): 2520-2522
Wierzejska, R. 2014: Designer drugs and caffeine - characteristics of psychoactive substances and their impact on the organism Developmental Period Medicine 18(3): 394-399
Khuwaja, A.K.; Ali, N.S.; Zafar, A.M. 2007: Use of psychoactive drugs among patients visiting outpatient clinics in Karachi, Pakistan Singapore Medical Journal 48(6): 509-513
Schayer, R.W.; Reilly, M.A. 1973: Effect of psychoactive drugs on in vivo metabolism of 14C-histamine in mouse brain Archives Internationales de Pharmacodynamie et de Therapie 203(1): 123-129
Nimkuntod, P.; Tongdee, P. 2016: Preclinical Medical Students' Achievement to Learning Outcomes in Special Tracts of Rural Doctors Journal of the Medical Association of Thailand 99 Suppl. 7: S105-S110